Our top pick for
Donegal Group Inc is an insurance-property & casualty business based in the US. Donegal Group shares (DGICA) are listed on the NASDAQ and all prices are listed in US Dollars.
|Latest market close||$14.62|
|52-week range||$13.08 - $16.14|
|50-day moving average||$14.71|
|200-day moving average||$15.13|
|Wall St. target price||$18.50|
|Dividend yield||$0.61 (4.14%)|
|Earnings per share (TTM)||$1.75|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-14)||-0.81%|
|1 month (2021-09-21)||4.13%|
|3 months (2021-07-21)||-5.62%|
|6 months (2021-04-21)||-10.31%|
|1 year (2020-10-21)||-1.55%|
|2 years (2019-10-21)||0.83%|
|3 years (2018-10-19)||6.40%|
|5 years (2016-10-21)||15.59|
Valuing Donegal Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Donegal Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Donegal Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 8x. In other words, Donegal Group shares trade at around 8x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Donegal Group's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.06. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Donegal Group's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Donegal Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $72.9 million.
The EBITDA is a measure of a Donegal Group's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$797.1 million|
|Operating margin TTM||8.32%|
|Gross profit TTM||$65.7 million|
|Return on assets TTM||1.91%|
|Return on equity TTM||10.23%|
|Market capitalisation||$455.6 million|
TTM: trailing 12 months
There are currently 145,012 Donegal Group shares held short by investors – that's known as Donegal Group's "short interest". This figure is 24.1% up from 116,828 last month.
There are a few different ways that this level of interest in shorting Donegal Group shares can be evaluated.
Donegal Group's "short interest ratio" (SIR) is the quantity of Donegal Group shares currently shorted divided by the average quantity of Donegal Group shares traded daily (recently around 45316.25). Donegal Group's SIR currently stands at 3.2. In other words for every 100,000 Donegal Group shares traded daily on the market, roughly 3200 shares are currently held short.
However Donegal Group's short interest can also be evaluated against the total number of Donegal Group shares, or, against the total number of tradable Donegal Group shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Donegal Group's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Donegal Group shares in existence, roughly 0 shares are currently held short) or 0.0095% of the tradable shares (for every 100,000 tradable Donegal Group shares, roughly 10 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Donegal Group.
Find out more about how you can short Donegal Group stock.
Dividend payout ratio: 43.66% of net profits
Recently Donegal Group has paid out, on average, around 43.66% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 4.34% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Donegal Group shareholders could enjoy a 4.34% return on their shares, in the form of dividend payments. In Donegal Group's case, that would currently equate to about $0.61 per share.
While Donegal Group's payout ratio might seem fairly standard, it's worth remembering that Donegal Group may be investing much of the rest of its net profits in future growth.
Donegal Group's most recent dividend payout was on 15 August 2021. The latest dividend was paid out to all shareholders who bought their shares by 29 July 2021 (the "ex-dividend date").
Donegal Group's shares were split on a 4:3 basis on 26 April 2006. So if you had owned 3 shares the day before before the split, the next day you'd have owned 4 shares. This wouldn't directly have changed the overall worth of your Donegal Group shares – just the quantity. However, indirectly, the new 25% lower share price could have impacted the market appetite for Donegal Group shares which in turn could have impacted Donegal Group's share price.
Over the last 12 months, Donegal Group's shares have ranged in value from as little as $13.0753 up to $16.1408. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Donegal Group's is 0.0651. This would suggest that Donegal Group's shares are less volatile than average (for this exchange).
Donegal Group Inc. , an insurance holding company, provides personal and commercial lines of property and casualty insurance to businesses and individuals in the Mid-Atlantic, Midwestern, New England, and southern states. It operates through four segments: Investment Function, Personal Lines of Insurance, and Commercial Lines of Insurance. The company offers private passenger automobile policies that provide protection against liability for bodily injury and property damage arising from automobile accidents, as well as protection against loss from damage to automobiles. It also offers homeowners policies, which provide coverage for damage to residences and their contents from a range of perils, including fire, lightning, windstorm, and theft; and liability of the insured arising from injury to other persons or their property. In addition, the company offers commercial automobile policies that provide protection against liability for bodily injury and property damage arising from automobile accidents and protection against loss from damage to automobiles owned by the insured; commercial multi-peril policies that provide protection to businesses against various perils, primarily combining liability and physical damage coverages; and workers' compensation policies, which provide benefits to employees for injuries sustained during employment. The company markets its insurance products through a network of approximately 2,400 independent insurance agencies.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.